Analogous to most immune mediators, whether IL-27 promotes or hinders malignant growth seems to be a matter of context.2 Nevertheless, given its clear effects on tumor progression, exploring the role of this cytokine in the setting of different cancer types represents an attractive research pursuit. The gene discussed is IL27; the disease is neoplasm.